Back
Top 7%
17.5%
Top 1%
8.9%
Top 4%
6.3%
Top 1%
5.9%
Top 2%
5.9%
Top 1.0%
5.0%
Top 82%
5.0%
Top 2%
3.8%
Top 67%
3.8%
Top 28%
3.8%
Top 20%
1.9%
Top 1%
1.9%
Top 0.7%
1.5%
Top 1%
1.5%
Top 12%
1.5%
Top 9%
1.5%
Top 1%
1.3%
Top 24%
0.9%
Top 6%
0.9%
Top 17%
0.9%
Top 5%
0.7%
Top 24%
0.7%
Top 30%
0.7%
How Low Could Semaglutide Prices Fall? An Analysis of Production Cost and Implications for Global Access Ahead of Patent Expiry
2026-03-04
endocrinology
Title + abstract only
View on medRxiv
Show abstract
ObjectivesTo estimate potential launch prices of generic semaglutide following patent expiry from 2026 and to quantify the global obesity and type 2 diabetes (T2DM) burden in countries where generic access may become possible. MethodsWe used World Bank population data and World Obesity and Diabetes Atlas prevalence estimates to calculate obesity and T2DM burden in countries where semaglutide patents expire in 2026 or were not filed. Patent status was identified using MedsPaL and cross-checked w...
Predicted journal destinations
1
BMJ Open
553 training papers
2
The Journal of Clinical Endocrinology & Metabolism
26 training papers
3
eLife
262 training papers
4
Frontiers in Endocrinology
20 training papers
5
BMC Medicine
155 training papers
6
Diabetologia
23 training papers
7
PLOS ONE
1737 training papers
8
PLOS Medicine
95 training papers
9
Scientific Reports
701 training papers
10
Nature Communications
483 training papers
11
PLOS Global Public Health
287 training papers
12
BMJ
49 training papers
13
Trials
24 training papers
14
Communications Medicine
63 training papers
15
BMJ Global Health
95 training papers
16
Proceedings of the National Academy of Sciences
100 training papers
17
International Journal of Obesity
17 training papers
18
JAMA Network Open
125 training papers
19
JMIR Public Health and Surveillance
45 training papers
20
npj Digital Medicine
85 training papers
21
Nutrients
43 training papers
22
Cureus
64 training papers
23
BMC Public Health
148 training papers